Lineage Cell Therapeutics In shares owned by Hanson McClain Advisors
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Hanson McClain Advisors
from 13F filings
Historical chart of Hanson McClain Advisors investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Hanson McClain Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $7.0k | 4.8k | 1.48 |
| 2023-12-31 | $5.2k | 4.8k | 1.09 |
| 2023-09-30 | $5.6k | 4.8k | 1.18 |
| 2023-06-30 | $6.7k | 4.8k | 1.41 |
| 2023-03-31 | $7.1k | 4.8k | 1.50 |
| 2022-12-31 | $5.6k | 4.8k | 1.17 |
| 2022-09-30 | $5.0k | 4.8k | 1.05 |
| 2022-06-30 | $8.0k | 4.8k | 1.68 |
| 2022-03-31 | $7.0k | 4.8k | 1.47 |
| 2021-12-31 | $12k | 4.8k | 2.53 |
| 2021-09-30 | $12k | 4.8k | 2.53 |
| 2021-06-30 | $14k | 4.8k | 2.95 |